Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

First phase I data presented for the neutrophil elastase inhibitor BI-1323495

Sep. 9, 2020

New personalized cystic fibrosis treatment treats Class V mutations

Sep. 9, 2020

Palobiofarma reports promising phase II data on PBF-680 for asthma

Sep. 7, 2020

Beijing Sanyou Liheze Biological Technology discovers potential stem cell therapy for COPD

Sep. 4, 2020

Nocion begins healthy volunteer study of NOC-100 for cough

Sep. 3, 2020

Cartesian initiates first-in-human study of Descartes-30 in patients with ARDS and COVID-19

Sep. 3, 2020

BMS details discovery and preclinical study of pulmonary fibrosis candidate BMS-986278

Aug. 31, 2020

Novartis discovers deltaF508 mutant CFTR correctors

Aug. 28, 2020

Mereo BioPharma initiates phase Ib/II study of alvelestat in COVID-19 respiratory disease

Aug. 26, 2020

Trevena initiates proof-of-concept study of TRV-027 in patients with COVID-19

Aug. 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...